Search Results 551-560 of 37416 for prostate cancer
The primary purpose of this study is to assess progression-free survival of men who have oligometastatic prostate cancer after randomization to stereotactic ...
This is a biomarker preselected, randomized, open-label, multicenter, phase II study in men with metastatic castration resistant prostate cancer (mCRPC).
Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side ...
Research. Doctors and scientists at Mayo Clinic are studying ways to improve detection of metastatic prostate cancer and recurrent prostate cancer, including ...
... prostate cancer. Clin Transl Radiat Oncol. 2026 Jul; 59:101168 Epub 2026 Apr 13. View PubMed; Tang C, Sherry AD, Hwang H, Farris DP, Francolini G, Di Cataldo ...
Meditation may help people with cancer by relieving anxiety and stress. Take a few minutes for yourself with this soothing guided meditation video. Prostate ...
"Surgery is a common treatment for prostate cancer, especially when we can confirm that the tumor is contained to the prostate. Obviously, physically.
The purpose of this study is to employ mixed methods approach to develop a prostate cancer survivorship care plan (CaP-SCP) tailored to US-born Black men (USbBM) ...
Prostate cancer experts at Mayo Clinic Comprehensive Cancer Center work in ... cancer, bladder cancer and kidney cancer. Oct. 31, 2014. Bladder cancer ...
... prostate cancer this year. While most forms of prostate cancer run an indolent course, metastatic castration-resistant prostate cancer (mCRPC) has an ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.